RT Journal Article
SR Electronic
T1 The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillance
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.04.17.22273906
DO 10.1101/2022.04.17.22273906
A1 Tegally, Houriiyah
A1 San, James E.
A1 Cotten, Matthew
A1 Tegomoh, Bryan
A1 Mboowa, Gerald
A1 Martin, Darren P.
A1 Baxter, Cheryl
A1 Moir, Monika
A1 Lambisia, Arnold
A1 Diallo, Amadou
A1 Amoako, Daniel G.
A1 Diagne, Moussa M.
A1 Sisay, Abay
A1 Zekri, Abdel-Rahman N.
A1 Barakat, Abdelhamid
A1 Gueye, Abdou Salam
A1 Sangare, Abdoul K.
A1 Ouedraogo, Abdoul-Salam
A1 Sow, Abdourahmane
A1 Musa, Abdualmoniem O.
A1 Sesay, Abdul K.
A1 Lagare, Adamou
A1 Kemi, Adedotun-Sulaiman
A1 Abar, Aden Elmi
A1 Johnson, Adeniji A.
A1 Fowotade, Adeola
A1 Olubusuyi, Adewumi M.
A1 Oluwapelumi, Adeyemi O.
A1 Amuri, Adrienne A.
A1 Juru, Agnes
A1 Ramadan, Ahmad Mabrouk
A1 Kandeil, Ahmed
A1 Mostafa, Ahmed
A1 Rebai, Ahmed
A1 Sayed, Ahmed
A1 Kazeem, Akano
A1 Balde, Aladje
A1 Christoffels, Alan
A1 Trotter, Alexander J.
A1 Campbell, Allan
A1 Keita, Alpha Kabinet
A1 Kone, Amadou
A1 Bouzid, Amal
A1 Souissi, Amal
A1 Agweyu, Ambrose
A1 Gutierrez, Ana V.
A1 Page, Andrew J.
A1 Yadouleton, Anges
A1 Vinze, Anika
A1 Happi, Anise N.
A1 Chouikha, Anissa
A1 Iranzadeh, Arash
A1 Maharaj, Arisha
A1 Batchi-Bouyou, Armel Landry
A1 Ismail, Arshad
A1 Sylverken, Augustina
A1 Goba, Augustine
A1 Femi, Ayoade
A1 Sijuwola, Ayotunde Elijah
A1 Ibrahimi, Azeddine
A1 Marycelin, Baba
A1 Salako, Babatunde Lawal
A1 Oderinde, Bamidele S.
A1 Bolajoko, Bankole
A1 Dhaala, Beatrice
A1 Herring, Belinda L.
A1 Tsofa, Benjamin
A1 Mvula, Bernard
A1 Njanpop-Lafourcade, Berthe-Marie
A1 Marondera, Blessing T.
A1 Khaireh, Bouh Abdi
A1 Kouriba, Bourema
A1 Adu, Bright
A1 Pool, Brigitte
A1 McInnis, Bronwyn
A1 Brook, Cara
A1 Williamson, Carolyn
A1 Anscombe, Catherine
A1 Pratt, Catherine B.
A1 Scheepers, Cathrine
A1 Akoua-Koffi, Chantal G.
A1 Agoti, Charles N.
A1 Loucoubar, Cheikh
A1 Onwuamah, Chika Kingsley
A1 Ihekweazu, Chikwe
A1 Malaka, Christian Noël
A1 Peyrefitte, Christophe
A1 Omoruyi, Chukwuma Ewean
A1 Rafaï, Clotaire Donatien
A1 Morang’a, Collins M.
A1 Nokes, D. James
A1 Lule, Daniel Bugembe
A1 Bridges, Daniel J.
A1 Mukadi-Bamuleka, Daniel
A1 Park, Danny
A1 Baker, David
A1 Doolabh, Deelan
A1 Ssemwanga, Deogratius
A1 Tshiabuila, Derek
A1 Bassirou, Diarra
A1 Amuzu, Dominic S.Y.
A1 Goedhals, Dominique
A1 Grant, Donald S.
A1 Omuoyo, Donwilliams O.
A1 Maruapula, Dorcas
A1 Wanjohi, Dorcas Waruguru
A1 Foster-Nyarko, Ebenezer
A1 Lusamaki, Eddy K.
A1 Simulundu, Edgar
A1 Ong’era, Edidah M.
A1 Ngabana, Edith N.
A1 Abworo, Edward O.
A1 Otieno, Edward
A1 Shumba, Edwin
A1 Barasa, Edwine
A1 Ahmed, El Bara
A1 Kampira, Elizabeth
A1 Fahime, Elmostafa El
A1 Lokilo, Emmanuel
A1 Mukantwari, Enatha
A1 Cyril, Erameh
A1 Philomena, Eromon
A1 Belarbi, Essia
A1 Simon-Loriere, Etienne
A1 Anoh, Etilé A.
A1 Leendertz, Fabian
A1 Taweh, Fahn M.
A1 Wasfi, Fares
A1 Abdelmoula, Fatma
A1 Takawira, Faustinos T.
A1 Derrar, Fawzi
A1 Ajogbasile, Fehintola V
A1 Treurnicht, Florette
A1 Onikepe, Folarin
A1 Ntoumi, Francine
A1 Muyembe, Francisca M.
A1 Ngiambudulu, Francisco
A1 Zongo Ragomzingba, Frank Edgard
A1 Dratibi, Fred Athanasius
A1 Iyanu, Fred-Akintunwa
A1 Mbunsu, Gabriel K.
A1 Thilliez, Gaetan
A1 Kay, Gemma L.
A1 Akpede, George O.
A1 George, Uwem E.
A1 van Zyl, Gert
A1 Awandare, Gordon A.
A1 Schubert, Grit
A1 Maphalala, Gugu P.
A1 Ranaivoson, Hafaliana C.
A1 Lemriss, Hajar
A1 Omunakwe, Hannah E
A1 Onywera, Harris
A1 Abe, Haruka
A1 Karray, Hela
A1 Nansumba, Hellen
A1 Triki, Henda
A1 Adje Kadjo, Herve Albéric
A1 Elgahzaly, Hesham
A1 Gumbo, Hlanai
A1 mathieu, Hota
A1 Kavunga-Membo, Hugo
A1 Smeti, Ibtihel
A1 Olawoye, Idowu B.
A1 Adetifa, Ifedayo
A1 Odia, Ikponmwosa
A1 Boubaker, Ilhem Boutiba-Ben
A1 Ssewanyana, Isaac
A1 Wurie, Isatta
A1 Konstantinus, Iyaloo S
A1 Afiwa Halatoko, Jacqueline Wemboo
A1 Ayei, James
A1 Sonoo, Janaki
A1 Lekana-Douki, Jean Bernard
A1 Makangara, Jean-Claude C.
A1 Tamfum, Jean-Jacques M.
A1 Heraud, Jean-Michel
A1 Shaffer, Jeffrey G.
A1 Giandhari, Jennifer
A1 Musyoki, Jennifer
A1 Uwanibe, Jessica N.
A1 Bhiman, Jinal N.
A1 Yasuda, Jiro
A1 Morais, Joana
A1 Mends, Joana Q.
A1 Kiconco, Jocelyn
A1 Sandi, John Demby
A1 Huddleston, John
A1 Odoom, John Kofi
A1 Morobe, John M.
A1 Gyapong, John O.
A1 Kayiwa, John T.
A1 Okolie, Johnson C.
A1 Xavier, Joicymara Santos
A1 Gyamfi, Jones
A1 Kofi Bonney, Joseph Humphrey
A1 Nyandwi, Joseph
A1 Everatt, Josie
A1 Farah, Jouali
A1 Nakaseegu, Joweria
A1 Ngoi, Joyce M.
A1 Namulondo, Joyce
A1 Oguzie, Judith U.
A1 Andeko, Julia C.
A1 Lutwama, Julius J.
A1 O’Grady, Justin
A1 Siddle, Katherine J
A1 Victoir, Kathleen
A1 Adeyemi, Kayode T.
A1 Tumedi, Kefentse A.
A1 Carvalho, Kevin Sanders
A1 Mohammed, Khadija Said
A1 Musonda, Kunda G.
A1 Duedu, Kwabena O.
A1 Belyamani, Lahcen
A1 Fki-Berrajah, Lamia
A1 Singh, Lavanya
A1 Biscornet, Leon
A1 de Oliveira Martins, Leonardo
A1 Chabuka, Lucious
A1 Olubayo, Luicer
A1 Deng, Lul Lojok
A1 Ochola-Oyier, Lynette Isabella
A1 Mine, Madisa
A1 Ramuth, Magalutcheemee
A1 Mastouri, Maha
A1 ElHefnawi, Mahmoud
A1 Mbanne, Maimouna
A1 Matsheka, Maitshwarelo I.
A1 Kebabonye, Malebogo
A1 Diop, Mamadou
A1 Momoh, Mambu
A1 Lima Mendonça, Maria da Luz
A1 Venter, Marietjie
A1 Paye, Marietou F
A1 Faye, Martin
A1 Nyaga, Martin M.
A1 Mareka, Mathabo
A1 Damaris, Matoke-Muhia
A1 Mburu, Maureen W.
A1 Mpina, Maximillian
A1 Claujens Chastel, Mfoutou Mapanguy
A1 Owusu, Michael
A1 Wiley, Michael R.
A1 Tatfeng, Mirabeau Youtchou
A1 Ayekaba, Mitoha Ondo’o
A1 Abouelhoda, Mohamed
A1 Beloufa, Mohamed Amine
A1 Seadawy, Mohamed G
A1 Khalifa, Mohamed K.
A1 Dellagi, Mohammed Koussai
A1 Matobo, Mooko Marethabile
A1 Kane, Mouhamed
A1 Ouadghiri, Mouna
A1 Salou, Mounerou
A1 Mbulawa, Mphaphi B.
A1 Saibu, Mudashiru Femi
A1 Mwenda, Mulenga
A1 Kaba, Muluken
A1 Phan, My V.T.
A1 Abid, Nabil
A1 Touil, Nadia
A1 Rujeni, Nadine
A1 Ismael, Nalia
A1 Top, Ndeye Marieme
A1 Dia, Ndongo
A1 Mabunda, Nédio
A1 Hsiao, Nei-yuan
A1 Silochi, Nelson Boricó
A1 Saasa, Ngonda
A1 Bbosa, Nicholas
A1 Murunga, Nickson
A1 Gumede, Nicksy
A1 Wolter, Nicole
A1 Sitharam, Nikita
A1 Ndodo, Nnaemeka
A1 Ajayi, Nnennaya A.
A1 Tordo, Noël
A1 Mbhele, Nokuzola
A1 Razanajatovo, Norosoa H
A1 Iguosadolo, Nosamiefan
A1 Mba, Nwando
A1 Kingsley, Ojide C.
A1 Sylvanus, Okogbenin
A1 Peter, Okokhere
A1 Femi, Oladiji
A1 Testimony, Olumade
A1 Ogunsanya, Olusola Akinola
A1 Fakayode, Oluwatosin
A1 Ogah, Onwe E.
A1 Faye, Ousmane
A1 Smith-Lawrence, Pamela
A1 Ondoa, Pascale
A1 Combe, Patrice
A1 Nabisubi, Patricia
A1 Semanda, Patrick
A1 Oluniyi, Paul E.
A1 Arnaldo, Paulo
A1 Quashie, Peter Kojo
A1 Bejon, Philip
A1 Dussart, Philippe
A1 Bester, Phillip A.
A1 Mbala, Placide K.
A1 Kaleebu, Pontiano
A1 Abechi, Priscilla
A1 El-Shesheny, Rabeh
A1 Joseph, Rageema
A1 Aziz, Ramy Karam
A1 Essomba, René Ghislain
A1 Ayivor-Djanie, Reuben
A1 Njouom, Richard
A1 Phillips, Richard O.
A1 Gorman, Richmond
A1 Kingsley, Robert A.
A1 Audu, Rosemary
A1 Carr, Rosina A.A.
A1 Kabbaj, Saâd El
A1 Gargouri, Saba
A1 Masmoudi, Saber
A1 Sankhe, Safietou
A1 Mohamed, Sahra Isse
A1 Mhalla, Salma
A1 Hosch, Salome
A1 Kassim, Samar Kamal
A1 Metha, Samar
A1 Trabelsi, Sameh
A1 Lemriss, Sanaâ
A1 Agwa, Sara Hassan
A1 Mwangi, Sarah Wambui
A1 Doumbia, Seydou
A1 Makiala-Mandanda, Sheila
A1 Aryeetey, Sherihane
A1 Ahmed, Shymaa S.
A1 Ahmed, Sidi Mohamed
A1 Elhamoumi, Siham
A1 Moyo, Sikhulile
A1 Lutucuta, Silvia
A1 Gaseitsiwe, Simani
A1 Jalloh, Simbirie
A1 Andriamandimby, Soafy
A1 Oguntope, Sobajo
A1 Grayo, Solène
A1 Lekana-Douki, Sonia
A1 Prosolek, Sophie
A1 Ouangraoua, Soumeya
A1 van Wyk, Stephanie
A1 Schaffner, Stephen F.
A1 Kanyerezi, Stephen
A1 Ahuka-Mundeke, Steve
A1 Rudder, Steven
A1 Pillay, Sureshnee
A1 Nabadda, Susan
A1 Behillil, Sylvie
A1 Budiaki, Sylvie L.
A1 van der Werf, Sylvie
A1 Mashe, Tapfumanei
A1 Aanniz, Tarik
A1 Mohale, Thabo
A1 Le-Viet, Thanh
A1 Velavan, Thirumalaisamy P.
A1 Schindler, Tobias
A1 Maponga, Tongai
A1 Bedford, Trevor
A1 Anyaneji, Ugochukwu J.
A1 Chinedu, Ugwu
A1 Ramphal, Upasana
A1 Enouf, Vincent
A1 Nene, Vishvanath
A1 Gorova, Vivianne
A1 Roshdy, Wael H.
A1 Karim, Wasim Abdul
A1 Ampofo, William K.
A1 Preiser, Wolfgang
A1 Choga, Wonderful T.
A1 Ahmed, Yahaya Ali
A1 Ramphal, Yajna
A1 Bediako, Yaw
A1 Naidoo, Yeshnee
A1 Butera, Yvan
A1 de Laurent, Zaydah R.
A1 Ouma, Ahmed E.O.
A1 von Gottberg, Anne
A1 Githinji, George
A1 Moeti, Matshidiso
A1 Tomori, Oyewale
A1 Sabeti, Pardis C.
A1 Sall, Amadou A.
A1 Oyola, Samuel O.
A1 Tebeje, Yenew K.
A1 Tessema, Sofonias K.
A1 de Oliveira, Tulio
A1 Happi, Christian
A1 Lessells, Richard
A1 Nkengasong, John
A1 Wilkinson, Eduan
YR 2022
UL http://medrxiv.org/content/early/2022/04/20/2022.04.17.22273906.abstract
AB Investment in Africa over the past year with regards to SARS-CoV-2 genotyping has led to a massive increase in the number of sequences, exceeding 100,000 genomes generated to track the pandemic on the continent. Our results show an increase in the number of African countries able to sequence within their own borders, coupled with a decrease in sequencing turnaround time. Findings from this genomic surveillance underscores the heterogeneous nature of the pandemic but we observe repeated dissemination of SARS-CoV-2 variants within the continent. Sustained investment for genomic surveillance in Africa is needed as the virus continues to evolve, particularly in the low vaccination landscape. These investments are very crucial for preparedness and response for future pathogen outbreaks.One-Sentence Summary Expanding Africa SARS-CoV-2 sequencing capacity in a fast evolving pandemic.Competing Interest StatementWith the exception of Pardis Sabeti who is a co-founder of and consultant to Sherlock Biosciences and a Board Member of Danaher Corporation and who holds equity in the companies, we the authors have no conflicts of interest to declare.Funding StatementSequencing efforts in the African Union Member States were supported by the Africa Center for Disease Control (Africa CDC) - Africa Pathogen Genomics Initiative (Africa PGI), and the World Health Organization Regional Office for Africa (WHO AFRO) through the transfer of laboratory infrastructure, the provision of reagents and training. The Africa PGI is supported by the African Union, Centers for Disease Control and Prevention (CDC), Bill and Melinda Gates Foundation (BMGF), Illumina Inc, Oxford Nanopore Technologies (ONT) and other partners. In addition, all Institut Pasteur organizations and CERMES in Niger are part of the PEPAIR COVID-19-Afirica project which is funded by the French Ministry for European and Foreign Affairs. KRISP and CERI is furthermore supported in part by grants from the World Health Organization, the Abbott Pandemic Defense Coalition (APDC), the National Institute of Health USA (U01 AI151698) for the United World Antivirus Research Network (UWARN) and the INFORM Africa project through IHVN (U54 TW012041), H3BioNet Africa (Grant # 2020 HTH 062), the South African Department of Science and Innovation (SA DSI) and the South African Medical Research Council (SAMRC) under the BRICS JAF #2020/049. ILRI is also supported by the Ministry for Economic Cooperation and Federal Development of Germany (BMZ). Work conducted at ACEGID is made possible by support provided to ACEGID by a cohort of generous donors through TED's Audacious Project, including the ELMA Foundation, MacKenzie Scott, the Skoll Foundation, and Open Philanthropy. Work at ACEGID was also partly supported by grants from the National Institute of Allergy and Infectious Diseases (https://www.niaid.nih.gov), NIH-H3Africa (https://h3africa.org) (U01HG007480 and U54HG007480), the World Bank (projects ACE-019 and ACE-IMPACT), the Rockefeller Foundation (Grant #2021 HTH), the Africa CDC through the African Society of Laboratory Medicine [ASLM] (Grant #INV018978), the Wellcome Trust (Project 216619/Z/19/Z) and the Science for Africa Foundation. Sequencing efforts at the National Institute for Communicable Diseases (NICD) was also supported by a conditional grant from the South African National Department of Health as part of the emergency COVID-19 response; a cooperative agreement between the National Institute for Communicable Diseases of the National Health Laboratory Service and the United States Centers for Disease Control and Prevention (FAIN# U01IP001048; NU51IP000930); the South African Medical Research Council (SAMRC, project number 96838); the African Society of Laboratory Medicine (ASLM) and the Bill and Melinda Gates Foundation grant number INV-018978; the UK Foreign, Commonwealth and Development Office and Wellcome (Grant no 221003/Z/20/Z); and the UK Department of Health and Social Care and managed by the Fleming Fund and performed under the auspices of the SEQAFRICA project. Funding for sequencing efforts in Angola was supported through Projecto Bongola (N. 11/MESCTI/PDCT/2020) and OGE INIS (2020/2021). Botswana's sequencing efforts led by the Botswana Harvard AIDS Institute Partnership was supported by: Foundation for Innovative New Diagnostics(FINDdx); Bill and Melinda Gates Foundation, H3ABioNet [U41HG006941], Sub-Saharan African Network for TB/HIV Research Excellence (SANTHE) and Fogarty International Center (Grant # 5D43TW009610) . H3ABioNet is an initiative of the Human Health and Heredity in Africa Consortium (H3Africa) programme of the African Academy of Science (AAS). HHS/NIH/National Institute of Allergy and Infectious Diseases (NIAID) (5K24AI131928-04; 5K24AI131924-04); SANTHE is a DELTAS Africa Initiative [grant # DEL-15-006]. The DELTAS Africa Initiative is an independent funding scheme of the African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA) and supported by the New Partnership for Africa's Development Planning and Coordinating Agency (NEPADAgency) with funding from the Wellcome Trust [grant #107752/Z/15/Z] and the United Kingdom (UK) government. From Brazil, Joicymara Santos Xavier was funded by Coordena'ao de Aperfei'oamento de Pessoal de Nivel Superior - Brazil (CAPES) - Finance Code 001. Sequencing efforts from Cote d'Ivoire were funded by the Robert Koch Institute and the German Federal Ministry of Education and Research (BMBF). Sequencing efforts in the Democratic Republic of the Congo were funded by the Bill & Melinda Gates Foundation under grant INV-018030 awarded to CBP and further supported by funding from the Africa CDC through the ASLM (African Society of Laboratory Medicine) for Accelerating SARS-CoV-2 Genomic Surveillance in Africa, the US Centre for Disease Control and Prevention (US CDC), USAMRIID, IRD/Montepellier, UCLA and SACIDS FIND. Efforts from Egypt was funded by the Egyptian Ministry of Health (REF#), the Egyptian Academy for Scientific Research and Technology (ASRT) JESOR project #3046 (Center for Genome and Microbiome Research), the Cairo University anti COVID-19 fund and the Science and Technology Development Fund (STDF), Project ID: 41907. The sequencing effort in Equatorial Guinea was supported by a public-private partnership, the Bioko Island Malaria Elimination Project, composed of the government of Equatorial Guinea Ministries of Mines and Hydrocarbons, and Health and Social Welfare, Marathon EG Production Limited, Noble Energy, Atlantic Methanol Production Company, and EG LNG. Analysis for the Gabon strains was supported by the Science and Technology Research Partnership for Sustainable Development (SATREPS), Japan International Cooperation Agency (JICA), and Japan Agency for Medical Research and Development (AMED) (grant number JP21jm0110013) and a grant from AMED (grant number JP21wm0225003). CIRMF (Gabon) is funded by the Gabonese Government and TOTAL Energy inc. CIRMF is a member of CANTAM supported by EDCTP. The work at WACCBIP (Ghana) was funded by a grant from the Rockefeller Foundation (2021 HTH 006), an Institut de Recherche pour le Developpement (IRD) grant (ARIACOV), African Research Universities Alliance (ARUA) Vaccine Development Hubs grant with funds from Open Society Foundation, National Institute of Health Research (NIHR) (17.63.91) grants using UK aid from the UK Government for a global health research group for Genomic surveillance of malaria in West Africa (Wellcome Sanger Institute, UK) and the World Bank African Centres of Excellence Impact grant (WACCBIP-NCDs: Awandare). In addition to the funding sources from ILRI, KEMRI (Kenyan) contributions to sequencing efforts was supported in part by the National Institute for Health Research (NIHR) (project references 17/63/82 and 16/136/33) using UK aid from the UK Government to support global health research, and The UK Foreign, Commonwealth and Development Office (FCDO) and Wellcome (grant# 220985/Z/20/Z) and the Kenya Medical Research Institute Grant # KEMRI/COV/SPE/012. Contributions from Lesotho was supported by the Africa CDC, African Society for Laboratory Medicine (ALSM) and the South African National Institute for Communicable Diseases (SA NICD). Liberian efforts was funded by the Africa CDC through a subaward from the Bill and Melinda Gates Foundations (REF#), while efforts from Madagascar were funded by the French Ministry for Europe and Foreign Affairs through the REPAIR COVID-19-Africa project coordinated by the Pasteur International Network association. Sequencing from Malawi was supported by Wellcome Trust (REF#). Contributions from Mali was supported by Fogarty International Center and National Institute of Allergy and Infectious Diseases sections of the National Institutes of Health under Leidos-15X051, award numbers U2RTW010673 for the West African Center of Excellence for Global Health Bioinformatics Research Training and U19AI089696 and U19AI129387 for the West Africa International Center of Excellence for Malaria Research. Sequencing efforts from Morocco have been supported by Academie Hassan II of Science and Technology, Morocco. Funding for surveillance, sampling and testing in Madagascar: World Health Organization (WHO), the US Centers for Disease Control and Prevention (US CDC: Grant#U5/IP000812-05), the United States Agency for International Development (USAID: Cooperation Agreement 72068719CA00001), the Office of the Assistant Secretary for Preparedness and Response in the U.S. Department of Health and Human Services (DHHS: grant number IDSEP190051-01-0200). Funding for sequencing: Bill & Melinda Gates Foundation (GCE/ID OPP1211841), Chan Zuckerberg Biohub, and the Innovative Genomics Institute at UC Berkeley. Mozambique acknowledges support from the Mozambican Ministry of Health and the Bill and Melinda Gates Foundation (REF#). Namibian efforts was supported by Africa CDC through a subaward from the Bill and Melinda Gates Foundations (REF#). Efforts from the country Niger were supported by the French Ministry for Europe and Foreign Affairs through the REPAIR COVID-19-Africa project coordinated by the Pasteur International Network association. In addition to the funding support for ACEGID already listed, Nigeria's contributions were made possible by support from Flu Lab and a cohort of generous donors through TED's Audacious Project, including the ELMA Foundation, MacKenzie Scott, the Skoll Foundation, and Open Philanthropy. Efforts from the Republic of the Congo was supported by the European and Developing Countries Clinical Trials Partnership (EDCTP) IDs: PANDORA, CANTAM and German Academic Exchange Service (DAAD) IDs: PACE-UP; DAAD Project ID: 5759234. Rwanda's contributions were made possible by funding from the African Network for improved Diagnostics, Epidemiology and Management of common Infectious Agents (ANDEMIA) was granted by the German Federal Ministry of Education and Research (BMBF grant 01KA1606, 01KA2021 and 01KA2110B) and the National Institute of Health Research (NIHR) Global Health Research programme (16/136/33) using UK aid from the UK Government. In addition to the South African institutions listed above, the University of Cape Town's work was supported by the Wellcome Trust [Grant # 203135/Z/16/Z], EDCTP RADIATES (RIA2020EF-3030), the South African Department of Science and Innovation (SA DSI) and the South African Medical Research Council (SAMRC), Stellenbosch University's contributions by the South African Medical Research Council (SA-MRC), and the University of Pretoria's contributions funded by the G7 Global Health Fund (REF#) and the BMBF ANDEMIA grant (REF#). Funding from the Fleming Fund (REF#) supported sequencing in Sudan. The Ministry of Higher Education and Scientific Research of Tunisia provided funding for sequencing from Tunisia. UVRI (Uganda) acknowledge support from the Wellcome Trust and FCDO - Wellcome Epidemic Preparedness - Coronavirus (AFRICO19, grant agreement number 220977/Z/20/Z), from the MRC (MC_UU_1201412) and from the UK Medical Research Council (MRC/UKRI) and FCDO (DIASEQCO, grant agreement number NC_PC_19060). Research at the FredHutch institute which supported bioinformatics analyses of sequences in the present study was supported by the Bill and Melinda Gates foundation (#INV-018979). Research support from Broad Institute colleagues was made possible by support from Flu lab and a cohort of generous donors through TED's Audacious Project, including the ELMA Foundation, MacKenzie Scott, the Skoll Foundation, Open Philanthropy, the Howard Hughes Medical Institute and NIH (U01AI151812 and U54HG007480) (P.C.S.). Work from Quadram Institute Bioscience was funded by The Biotechnology and Biological Sciences Research Council Institute Strategic Programme Microbes in the Food Chain BB/R012504/1 and its constituent projects BBS/E/F/000PR10348, BBS/E/F/000PR10349, BBS/E/F/000PR10351, and BBS/E/F/000PR10352 and by the Quadram Institute Bioscience BBSRC funded Core Capability Grant (project number BB/CCG1860/1). Sequences generated in Zambia through PATH were funded by the Bill & Melinda Gates Foundation and Africa CDC (REF#). The content and findings reported herein are the sole deduction, view and responsibility of the researcher/s and do not reflect the official position and sentiments of the funding agencies. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The African samples processed in this study were obtained anonymously from material exceeding the routine diagnosis of SARS- CoV-2 in African public and private health laboratories. Individual institutional review board (IRB) references or material transfer agreements (MTAs) for countries are listed in the PDF under Material and Methods: Ethics statement.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll of the SARS-CoV-2 whole genome sequences that were analyzed in the present study are all publicly available on the GISAID sequence database. A full list of the African sequences as well as global references are presented and acknowledged in Supplementary Table S3 and in our data repository, which will be made public at final publication. The github repo also contains all of the alignments, raw and time scaled ML tree topologies, data analysis and visualization scripts used here which will allow for the independent reproduction of results.